Latest News
Trump to sign executive order on psychedelic drug used abroad to treat PTSD
Ibogaine is used in Mexico and the Caribbean to treat depression, anxiety, addiction and brain trauma.
Psychedelics & Healing Initiative Trends for 2026
Psychedelics & Healing Initiative 2026 Trends Initiative Chair: Mary-Elizabeth Gifford, EVP, Psyence, United States Initiative Vice-Chair: Julia Mirer, MD, Director of Strategy, NeuroPain Health, United States Initiative Vice-Chair: Rick Doblin, Pdh, Founder & Executive Director, Multidisciplinary Association for Psychedelic Studies (MAPS), United States If it seems the world is falling in love with psychedelics, it may be easy to understand why. Ground-breaking studies on these innovative…
Inspiring Conversations with Teddy Brenner of Tranquil Soul Balance
DEA Boosts Legal Production Levels For Psychedelics Like Psilocybin And DMT In Final Rule For 2026
The Drug Enforcement Administration (DEA) has finalized quotas for legal production of controlled substances in 2026—further raising the amount of certain psychedelics that can be made for research purposes in the new year. In a notice published in the Federal Register on Monday, DEA increased its quotas for psilocybin, psilocyn and DMT compared to what […]
Psychedelic Science conference returns to Denver
The MAPS event runs June 16-20.
Single psilocybin trip delivers two years of depression relief for cancer patients
Psilocybin, the active ingredient in magic mushrooms, might just revolutionize how depression and anxiety are treated in cancer patients. In a groundbreaking trial, a single dose combined with therapy significantly reduced emotional suffering, and these effects often lasted over two years. As follow-up studies expand the research to multiple doses and larger samples, scientists are eyeing a possible new standard of care that merges psychedelics with psychological support.
Texas Invests $50M in Psychedelic Drug Research to Treat Addiction
Texas is putting $50M into ibogaine research to explore its use in treating addiction and PTSD.
Depression: Five Million Americans May Benefit From Psychedelic Therapy
Breakthrough therapy designations have been granted to use the active ingredient in magic mushrooms to treat depression and a broader approval may be coming.
The rise, challenges and future
FDA has issued psychedelic guidance, but the industry is struggling as decriminalization efforts gain traction and approval looms.
Latest research and treatments
Learn about the latest research on neuroplasticity and mental health, including how psychedelics are being investigated for mood disorders.
Oregon Psilocybin: Banking
Part two of this series covers the following Oregon psilocybin business issues: banking, raising money and licensed business siting.
Oregon Psilocybin: Business Issues
Oregon psilocybin businesses will be subject to residency requirements, financial interest rules, and a heavy tax burden.
Mushroom Extract Outperforms Synthetic Psilocybin in Psychiatric Therapy
A new study reveals that psilocybin-containing mushroom extract exhibits a more potent and enduring effect on synaptic plasticity compared to its synthetic counterpart.
A single dose of psilocybin boosts neuroplasticity and reduces depression symptoms
A recent study published in the Journal of Psychopharmacology suggests that psilocybin, the active component in "magic mushrooms", can induce lasting neuroplastic changes in the brain, which are associated with improvements in symptoms of depression. The research, which found significant increases in a specific EEG measure of neuroplasticity two weeks after a single psilocybin treatment session, heralds a promising avenue for depression treatment, albeit requiring further studies with larger and more diverse sample groups. ...
How Magic Mushrooms Could Change Your Mind-Body Connection
Psilocybin could be a game-changer in helping people reconnect with their body.
Psychedelic-Assisted Therapy
Psychedelic-assisted therapy refers to therapeutic practices that involve the ingestion of a psychedelic drug. Since the early 1990s, a new generation of scientists has revived the research. Clinical trials have shown that ingesting a psychedelic in a carefully prescribed and monitored setting can induce an experience that is medically safe and that provokes profound, durable psychological and behavioral change.
Silo Pharma looks into the crystal ball
We asked James Kuo, vice president of R&D at Silo Pharma, about his predictions for the field of psychedelic research in 2023.
How psychedelic drugs may help with depression
Psychedelic drugs being tested as therapies for treatment-resistant depression activate receptors within brain cells that promote new brain cell connections.
The Future of MDMA, Psilocybin, and Psychedelics in the U.S.
Australia will soon allow psychedelics MDMA and psilocybin to be used medically. The U.S. may not be too far behind, some experts say.
Psychedelic Therapy for Mental Health: What You Need To Know in 2023
According to a meta-analysis that was published in the Journal of Psychoactive Drugs, psychedelic-assisted therapy was found to be significantly more effective in treating anxiety and depression in pa
Psychedelic Research Renaissance
Psychedelics such as LSD, psilocybin and MDMA are gaining increasing attention in scientific and medical circles because of the potential they hold for treating anxiety disorders and emotional trauma. UC's Nese Devenot explains why psychedelics are seeing a research renaissance.
Top psychedelic researchers featured in new video series
Lectures from the 2023 Psychedelic Summit explore the possibilities and limitations of psychedelics to treat anxiety, depression, PTSD and other disorders.
Magic mushrooms MDMA psychedelic therapy : NPR
Thousands are in Denver this week to learn about the future of psychedelics like magic mushrooms and MDMA, and to talk business.
Why 2023 Could Be a Pivotal Year for Psychedelic-Assisted Treatment
After years of regulatory hurdles and societal stigma, psychedelic-assisted treatment for behavioral health conditions is coming into the spotlight.
From promise to practice: A dose of reality for psychedelic therapies
Psychedelic therapy at a crossroads at the dawn of 2023
In several ways, psychedelic therapy continued to make strides toward legitimization in 2022, but certainly not in an all.
Why Psychedelics Are Therapy's Next Frontier
What psychedelics really feel like, and where they can take us.
Luminous: A Series About Psychedelics from 'To The Best Of Our Knowledge'
Are you ready for the psychedelic revolution? In the next few years, the FDA is likely to approve these mind-bending drugs for treating depression and post-traumatic stress disorder. Some states have already decriminalized psilocybin, the active ingredient in "magic" mushrooms. But for all the headlines, many questions are swirling around this psychedelic renaissance. How do we make these drugs effective, safe and accessible to the people who need the most help? And how can they be used ethically, when much of the knowledge about plant medicines comes from Indigenous cultures? Psychedelics also raise profound questions about the nature of consciousness and mystical experience. People often describe their psychedelic experiences as "more real" than everyday life. Is this just an illusion, or do these experiences tap into some deeper reality? In "Luminous," TTBOOK executive producer Steve Paulson explores the philosophical and cultural implications of psychedelics through conversations with scientists, healers and religious scholars. You can listen to each episode on the radio or find the series plus bonus extended conversations on Apple Podcasts, Spotify, YouTube or wherever you get your podcasts.
Psychedelic Therapy Requires Enhanced Consent Discussions
The presenters at an Annual Meeting session cautioned that patients pursuing psychedelic-assisted psychotherapy will benefit from physicians offering more, not less, information about the myriad ou...
Is the Psychedelic Therapy Bubble About to Burst?
A new paper argues that excitement has veered into misinformation—and scientists should be the ones to set things straight.
Psilocybin Treatment for Major Depression Effective for Up to a Year for Most Patients, Study Shows
Advanced brain imaging study hints at how DMT psychedelic alters perception of reality
Scientists have gleaned new insights into how psychedelics alter conscious experience via their action on brain activity.
What Does Good Psychedelic Therapy Look Like?
As MDMA and psilocybin treatments become more mainstream, the therapy component has come under scrutiny. Here’s what’s common in many sessions — and what’s not.
Mushrooms magnify memory by boosting nerve growth
Researchers have discovered the active compound from an edible mushroom that boosts nerve growth and enhances memory.
MDMA: Australia begins world-first psychedelic therapy
The drug and a key ingredient in magic mushrooms will be used nationally to treat PTSD and depression.